Tango Therapeutics Inc (TNGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 28,381 | N/A | N/A | N/A |
| Marketable Securities | 161,939 | N/A | N/A | N/A |
| Receivables | 2,000 | N/A | N/A | N/A |
| TOTAL | $193,632 | $N/A | $N/A | $N/A |
| Non-Current Assets | ||||
| PPE Net | 3,823 | N/A | N/A | N/A |
| Other Non-Current Assets | 9,797 | 0 | 0 | 0 |
| TOTAL | $13,620 | $N/A | $N/A | $N/A |
| Total Assets | $207,252 | $N/A | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 1,841 | 0 | 0 | 0 |
| Accrued Expenses | 6,140 | N/A | N/A | N/A |
| TOTAL | $40,917 | $N/A | $N/A | $N/A |
| Non-Current Liabilities | ||||
| Deferred Revenues | 31,977 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 6,930 | 0 | 0 | 0 |
| TOTAL | $127,735 | $N/A | $N/A | $N/A |
| Total Liabilities | $168,652 | $N/A | $N/A | $N/A |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 21,377 | N/A | N/A | N/A |
| Common Shares | 40 | N/A | N/A | N/A |
| Retained earnings | -103,101 | N/A | N/A | N/A |
| Other shareholders' equity | 17 | 0 | 0 | 0 |
| TOTAL | $38,600 | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $207,252 | $0 | $0 | $0 |